The XFL and NeuroSync today announced a partnership that establishes NeuroSync’s award-winning EYE-SYNC technology as the Official and Exclusive Concussion Management Technology of the XFL.
Read articleSyncThink, a next generation neurotechnology company, and makers of the award-winning EYE-SYNC technology, announces today that it will rebrand the company as NeuroSync, as it looks to grow its stance in the neurological health market.
Read articlePalo Alto, CA and Boston MA – August 10, 2022 – SyncThink, a next generation neurotechnology company, and makers of the award-winning EYE-SYNC technology, announces today that it has completed CE Mark certification, affirming conformity to European Medical Device Regulation (MDR), also known as ISO 13485. EYE-SYNC will be registered as a Class I medical device.
Read articlePalo Alto and Boston – March 29, 2022– SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today the expansion of its clinical advisory board and the creation of a specific advisory panel of Physical Therapy providers, to assist the company with growing product demand and market opportunities.
Read articlePalo Alto and Boston–March 9, 2022– SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today the expansion of its partnership with Pico Interactive, a global technology company that develops innovative VR and enterprise solutions, and the integration of its platform onto the Pico Neo 3 Pro Eye headset.
Read articlePalo Alto and Boston—October 5, 2021— SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today the US Food and Drug Administration (FDA) has granted clearance of the EYE-SYNC technology as an Aid to Concussion, or mild Traumatic Brain Injury (mTBI) Diagnosis. EYE-SYNC previously received the prestigious Breakthrough Device Designation from the FDA in 2019, following the initial clearance and commercialization of the technology platform in 2017.
Read articlePalo Alto and Boston – April 5, 2021– SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today it has partnered with Tobii, the world leader in eye tracking, and Pico Interactive, a global technology company that develops innovative VR and enterprise solutions. The company will provide EYE-SYNC on the Pico Neo 2 Eye, which was recently named one of TIME’s best inventions of 2020.
Read articlePalo Alto, CA—January 04, 2021— SyncThink, a world leader in neurotechnology with foundational IP in eye-tracking analytics, and creators of the award-winning EYE-SYNC brain health platform, announces today its partnership with Daybrook Strategies of Saint Louis. Daybrook, a joint venture between local providers Advanced Neuro Performance and The Center for Vision and Learning, plan to incorporate the novel eye tracking solution as part of an effort to develop a statewide concussion management program.
Read articlePalo Alto, CA– May 11, 2020— SyncThink, a world leader in neurotechnology and brain health analytics and creators of EYE-SYNC technology, and TeachAids, a nonprofit social enterprise behind the CrashCourse concussion education technology, join forces. This partnership is a perfect complement, bringing together much needed concussion prevention education with a renowned assessment tool in Virtual Reality.
Read articleSyncThink, a world leader in neurotechnology and brain health analytics, announces today its award-winning technology, EYE-SYNC is the recipient of Breakthrough Device Designation from the Food and Drug Administration.
Read articleTwellman hopes to make soccer safer through evangelizing novel technology.
Read articleAs announced at CES 2019…
Read article